Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07187206 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of FETO in CDH Phase III
A Phase 3 study of Pulmonary Hypertension and Congenital Diaphragmatic Hernia, sponsored by Children's Hospital Medical Center, Cincinnati.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 75
- Enrollment target
- 1
- Study location
NCT07187206: Recruiting Phase 3 study of Pulmonary Hypertension and Congenital Diaphragmatic Hernia, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07187206 is a Phase 3 study of Pulmonary Hypertension and Congenital Diaphragmatic Hernia that is actively recruiting participants, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 75 participants, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07187206, a Phase 3 study of Pulmonary Hypertension and Congenital Diaphragmatic Hernia, is actively recruiting participants, sponsored by Children's Hospital Medical Center, Cincinnati.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group
Primary Outcome
Change in o/eLHR and other prenatal imaging tests
Conditions Studied
Interventions
- DEVICE FETO, Fetal Endoluminal Tracheal Occlusion
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center (CCHMC) - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-09-30 |
| Est. Completion | 2033-03-01 |
| Phase | Phase 3 |
What NCT07187206 shows while recruiting
NCT07187206 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 613-participant average among 72 other Pulmonary Hypertension trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Pulmonary Hypertension appearing as the primary indexed condition, and to 1 intervention - of which FETO, Fetal Endoluminal Tracheal Occlusion is the first listed.
NCT07187206 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07187206 about?
NCT07187206 is a clinical study titled "Safety and Efficacy of FETO in CDH Phase III". Tracheal occlusion IDE approved by FDA for congenital diaphragmatic hernia fetuses and standard of care control group
What is the current status of trial NCT07187206?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 75 participants. The study started on 2025-09-30. Estimated completion is 2033-03-01.
What conditions does trial NCT07187206 study?
This clinical trial studies the following conditions: Pulmonary Hypertension, Congenital Diaphragmatic Hernia, Pulmonary Hypoplasia.
What interventions are being tested in trial NCT07187206?
The interventions under investigation include: FETO, Fetal Endoluminal Tracheal Occlusion (DEVICE).
Who is sponsoring clinical trial NCT07187206?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07187206 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07187206's enrollment target sits among peer trials
75 35th of 72 higher than 38 of 72 other Pulmonary Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
RECRUITING · Phase 3
-
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
RECRUITING · Phase 3
-
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
COMPLETED · Phase 3
-
Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
COMPLETED · Phase 3
-
Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension
COMPLETED · Phase 3
-
A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI